Amanda Fuller[/caption]
This activity is sponsored by PDL. This information is general in nature and designed only to highlight issues for your consideration. Before acting on this information, you should consider your individual circumstances and needs, and obtain advice as appropriate.[/caption]
Risk factors for child poisoning
Communication: Effective communication between pharmacists and patients, parents and carers is vital to ensure the safe use of medicines and an awareness of the potential risks that may come with a medicine. Communication should be tailored to account for the socioeconomic, cultural, or educational background of the patient or carer. Counselling should include not only the dose, frequency and duration of therapy for medicines prescribed to children, but also information about safe storage, accessibility and disposal of that medicine. Accessibility and disposal are relevant in any situation where a child might be present.12 Pharmacists should promote the return of unused or unwanted medicines to the pharmacy for safe disposal, helping to reduce the risk of poisoning exposure.
Viknesh 
Alfred 
Eric Khek[/caption]
Krysti-Lee Patterson MPS[/caption]
From the President: Caring for older Australians with compassion and expertise
At PSA we are proud to advocate for the critical role that pharmacists play in palliative care and aged care for medication supply and...
Metformin for wet (neovascular) age-related macular degeneration
References
Khanna S, Shaw L, Hyman MJ, et al. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina...
Changes to AIR information
References
1. Australian Government Department of Health and Aged Care. Mandatory reporting changes to the Australian Immunisation Register (AIR) from 1 March 2024. 2024. At:...
How to deliver respectful, reliable service when dispensing PrEP
When dispensing PrEP medication, it's critical to strike the right balance between a patient's right to privacy and ensuring they have been told everything...
Long-acting treatment for opioid dependence approved
The first long-acting treatment for opioid dependence has been approved for use in Australia by the Therapeutic Goods Administration (TGA).
Buvidal Weekly and Buvidal Monthly...
